Amsterdam UMC Stichting

Oncology and Cancer Care

Amsterdam UMC conducts clinical research across a broad range of cancer types, with strong activity in pancreatic cancer, esophageal cancer, lung cancer, melanoma, breast cancer, bladder cancer, colorectal cancer, prostate cancer, and cholangiocarcinoma. Its studies also include advanced and metastatic disease, along with tumour-focused imaging and immunotherapy-related work.

  • Pancreatic cancer
  • Esophageal and esophagogastric cancer
  • Melanoma and skin cancer
  • Lung and bladder cancer
  • Tumour imaging and immunotherapy

Research interests extend to surgical oncology, perioperative treatment, and biomarker-driven approaches in gastrointestinal and solid tumours.

Inflammatory, Autoimmune, and Fibrotic Disease

The sponsor supports studies in inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, as well as rheumatoid arthritis, systemic lupus erythematodes, lupus nephritis, multiple sclerosis, psoriasis, atopic eczema, and chronic rhinosinusitis with nasal polyps. It also investigates fibrotic and immune-mediated conditions affecting the lungs, kidneys, and other organs.

  • Crohn’s disease and ulcerative colitis
  • Lupus nephritis and systemic lupus erythematodes
  • Multiple sclerosis and inflammatory myopathy
  • Psoriasis and atopic eczema
  • Fibrosis in gut, lung, and kidney disease

Work in this area includes immune modulation, tissue inflammation, and organ-specific fibrotic change.

Neurology, Neurodegeneration, and Rare Neuromuscular Disorders

Amsterdam UMC is active in Alzheimer’s disease, dementia, mild cognitive impairment, Parkinson’s disease, post-traumatic stress disorder, insomnia, and major depressive disorder. Its portfolio also includes rare neurological and neuromuscular disorders such as vanishing white matter, fragile X syndrome, tuberous sclerosis complex, Sanfilippo syndrome, Gaucher disease type 3, and multiple sclerosis.

  • Alzheimer’s disease and dementia
  • Parkinson’s disease
  • Multiple sclerosis
  • Rare neurogenetic syndromes
  • Psychiatric and sleep-related disorders

Research also covers symptom control, neuroimaging, and functional outcomes in neurological disease.

Cardiovascular, Metabolic, and Renal Medicine

The sponsor funds research in acute coronary syndrome, myocardial infarction, atrial fibrillation, coronary artery disease, aortic valve stenosis, pulmonary arterial hypertension, vasospastic angina, and stroke. It also studies type 2 diabetes, diabetes mellitus, obesity, kidney failure, acute kidney injury, kidney transplantation, and lupus nephritis.

  • Coronary and rhythm disorders
  • Stroke and vascular disease
  • Diabetes and metabolic regulation
  • Kidney failure and transplantation
  • Pulmonary hypertension

Clinical work in this domain includes cardiovascular risk, haemodynamic disease, and renal protection.

Women’s Health, Reproductive Medicine, and Pregnancy

Amsterdam UMC shows active interest in menopause, climacteric symptoms, polycystic ovary syndrome, infertility, uterine fibroids, placenta previa, preterm birth, preterm preeclampsia, and other hypertensive disorders of pregnancy. Its research also includes reproductive and hormonal health in transgender women receiving gender-affirming hormone therapy.

  • Menopause and climacteric symptoms
  • Infertility and polycystic ovary syndrome
  • Pregnancy complications
  • Uterine and placental disorders
  • Gender-affirming hormone therapy

Studies in this area address endocrine balance, maternal-fetal health, and reproductive function.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effects of Saracatinib for Patients with Fibrodysplasia Ossificans Progressiva (FOP)

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands
  • Study on the Safety of Lutetium (177Lu) Zadavotide Guraxetan and Radium Ra 223 Dichloride for Patients with Bone-Metastatic Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    The Netherlands
  • Study of levamisole and prednisolone combination to prevent nephrotic syndrome relapse in children aged 2-16 years with first episode of steroid-sensitive disease

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effects of Intradermal IMO-2125 (Tilsotolimod) for Patients with Advanced Melanoma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Austria Italy The Netherlands Spain
  • Study on the Use of Casirivimab, Cilgavimab, Sotrovimab, and Nirmatrelvir for Patients with COVID-19 Infection

    Not recruiting

    3 1 1 1
    The Netherlands